FDA PDUFA goal date for Oxnimbi (aroxybutynin and atomoxetine) oral NDA.
FDA catalyst calendar
Confirmed PDUFA dates, advisory committees and Phase 3 readouts. Every entry links to its primary source.
1 events · Clear filters
February 2027 1
- 28Feb
Apnimed, Inc. — Oxnimbi (AD109)